Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Daniel Kaping
Levels of 17β-Hydroxysteroid Dehydrogenase Type 10 in CSF Are Not a Valuable Biomarker for Multiple Sclerosis
Biomarkers in Medicine
Biochemistry
Drug Discovery
Clinical Biochemistry
Related publications
Undetectable Levels of CSF Amyloid-Β Peptide in a Patient With 17β-Hydroxysteroid Dehydrogenase Deficiency
Journal of Alzheimer's Disease
Gerontology
Clinical Psychology
Mental Health
Psychiatry
Geriatrics
Medicine
Neuroscience
Overexpression of 17β-Hydroxysteroid Dehydrogenase Type 10 Increases Pheochromocytoma Cell Growth and Resistance to Cell Death
BMC Cancer
Cancer Research
Oncology
Genetics
Comparative Evolutionary Genomics of the HADH2 Gene Encoding Aβ-Binding Alcohol Dehydrogenase/17β-Hydroxysteroid Dehydrogenase Type 10 (ABAD/HSD10)
BMC Genomics
Biotechnology
Genetics
Transcriptional Regulation of Type 11 17β-Hydroxysteroid Dehydrogenase Expression in Prostate Cancer Cells
Molecular and Cellular Endocrinology
Biochemistry
Endocrinology
Molecular Biology
Circulating miR-150 in CSF Is a Novel Candidate Biomarker for Multiple Sclerosis
Neurology: Neuroimmunology and NeuroInflammation
Neurology
Structural Basis for Species Specific Inhibition of 17β-Hydroxysteroid Dehydrogenase Type 1 (17β-Hsd1): Computational Study and Biological Validation
PLoS ONE
Multidisciplinary
Complexities of Gender Assignment in 17β-Hydroxysteroid Dehydrogenase Type 3 Deficiency: Is There a Role for Early Orchiectomy?
International Journal of Pediatric Endocrinology
Child Health
Endocrinology
Perinatology
Pediatrics
Metabolism
Diabetes
Fingolimod and CSF Neurofilament Light Chain Levels in Relapsing-Remitting Multiple Sclerosis
Neurology
Neurology
Characterization of Ke 6, a New 17β-Hydroxysteroid Dehydrogenase, and Its Expression in Gonadal Tissues
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology